Table 3.
Effect of carbamazepine (CBZ) on lapatinib (LAP) pharmacokinetics
Parameter | LAP alone* (n= 24) | LAP + CBZ* (n= 23) | Comparison† (n= 23) |
---|---|---|---|
AUC, h ng−1 ml−1 | 3526 (2888, 4306) | 984 (826, 1171) | 0.28 (0.23, 0.32) |
Cmax, ng ml−1 | 261 (209, 327) | 110 (90.5, 134) | 0.41 (0.34, 0.51) |
tmax, h | 4.0 (2.5, 6.0) | 3.0 (1.0, 8.0) | −0.21 (−0.70, 0.76) |
tlag, h | 0.12 (0.00, 0.50) | 0.25 (0.00, 1.00) | 0.00 (0.00, 0.14) |
ka, h−1 | 0.70 (0.59, 0.82) | 0.50 (0.39, 0.63) | 0.72 (0.54, 0.96) |
t1/2, h | 10.2 (9.24, 11.3) | 9.98 (8.12, 12.3) | 0.98 (0.80, 1.19) |
Geometric mean (95% CI) for AUC, Cmax, ka, t1/2; median (range) for tlag and tmax.
Geometric least-squares mean ratio (95% CI) for AUC, Cmax, ka, t1/2; median difference for tmax and tlag.